In this explanatory monologue, the speaker describes the mitochondrial peptide MOTS‑c as a cellular distress signal (SOTC) that reprograms whole‑body metabolism to cope with stress and improve future performance. MOTS‑c activates AMPK, the primary energy sensor, which raises insulin sensitivity, allowing cells to import glucose directly from the bloodstream. It also drives the clearance of stagnant fatty acids that block insulin receptors and opens a gateway for fatty‑acid oxidation within mitochondria. Additionally, MOTS‑c triggers mitochondrial DNA replication and the formation of new mitochondria, expanding ATP‑producing capacity, enhancing waste clearance, and permanently upgrading metabolic capacity. The peptide further acts as an exercise‑mimetic, improving muscular endurance by shifting muscle cells toward an endurance phenotype. The speaker notes that MOTS‑c is naturally released during exercise, fasting, and cold exposure, and raises the question of what effects might arise from exogenous supplementation of the peptide.
